CME Session
Hybrid Session
Payal Kapur, MD
University of Texas Southwestern
Disclosure: Disclosure(s): No financial relationships to disclose
Ivan Pedrosa, MD PhD
University of Texas Southwestern
Disclosure: Disclosure(s): No relevant disclosure to display
Steven Chang, MD, MS
Dana-Farbe/Brigham and Women's Cancer Center
Boston, Massachusetts, United States
Disclosure: Disclosure(s): No financial relationships to disclose
Stephanie Berg, DO (she/her/hers)
Dana-Farber Cancer Institute
Needham, Massachusetts, United States
Disclosure: Disclosure(s): Non-CE Consulting: BMS (Ongoing); Exelixis (Ongoing); Pfizer (Ongoing); Sanofi (Ongoing); SeaGen (Ongoing)
Non-CE Speakers Bureau: BMS (Terminated, June 30, 2022); Eisai (Terminated, June 30, 2022); Exelixis (Terminated, June 30, 2022)
Chad Tang, MD
University of Texas MD Anderson Cancer Center
Disclosure: Disclosure(s): Non-CE Consulting: Diffusion Pharmaceuticals (Ongoing)
Non-CE Speakers Bureau: Bayer (Terminated, September 28, 2021)
Royalty: Wolters Kluwer (Ongoing)